Bispecific EGFR/IGFIR binding molecules
The present invention relates to bispecific molecules comprising an EGFR binding domain and a distinct IGFIR binding domain for use in diagnostic, research and therapeutic applications. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and vectors comprising the polynucleotides encoding the innovative proteins. Exemplary bispecific molecules include antibody-like protein dimers based on the tenth fibronectin type III domain.
1. An antibody-like protein comprising a tenth fibronectin type III domain ( 10 Fn3) that binds epidermal growth factor receptor (EGFR) with a K D of less than 500 nM, wherein the EGFR binding 10 Fn3 comprises a BC loop having the amino acid sequence set forth in amino acids 21-30 of SEQ ID NO: 112, a DE loop having the amino acid sequence set forth in amino acids 51-56 of SEQ ID NO: 112, and an FG loop having the amino acid sequence set forth in amino acids 76-92 of SEQ ID NO: 112.
2. The antibody-like protein of claim 1 , further comprising a second tenth fibronectin type III domain (10Fn3).
3. The antibody-like protein of claim 2 , wherein the second 10 Fn3 is covalently linked to the EGFR binding 10 Fn3 via a polypeptide linker or a polyethylene glycol moiety.
4. A pharmaceutically acceptable composition comprising the antibody-like protein of claim 1 , wherein the composition is essentially pyrogen free.
5. The antibody-like protein of claim 1 , comprising an amino acid sequence at least 90% identical to SEQ ID NO: 112.
6. The antibody-like protein of claim 5 , comprising an amino acid sequence at least 95% identical to SEQ ID NO: 112.
7. The antibody-like protein of claim 6 , comprising an amino acid sequence at least 98% identical to SEQ ID NO: 112.
8. An antibody-like protein comprising the amino acid sequence of SEQ ID NO: 112.
9. An antibody-like protein comprising a tenth fibronectin type III domain ( 10 Fn3) that binds epidermal growth factor receptor (EGFR) with a K D of less than 500 nM, wherein the EGFR binding 10 Fn3 comprises a BC loop having the amino acid sequence X g WAPVDRYQX h (SEQ ID NO: 137), a DE loop having the amino acid sequence X i RDVYX J (SEQ ID NO: 138), and an FG loop having the amino acid sequence X k DYKPHADGPHTYHESX l (SEQ ID NO: 139); and wherein X is any amino acid and g, h, i, j, k, and l are integers independently selected from 0 to 5.
10. The antibody-like protein of claim 9 , wherein the EGFR binding 10 Fn3 comprises a BC loop having the amino acid sequence SWWAPVDRYQ (SEQ ID NO: 115), a DE loop having the amino acid sequence PRDVYT (SEQ ID NO: 116), and an FG loop having the amino acid sequence TDYKPHADGPHTYHESP (SEQ ID NO: 117).